Ensuring access to medicine for all in LMICs
Addressing global access to medicine, particularly in LMICs, poses a significant challenge. As COVID-19 vaccines are distributed, how can the pharmaceutical industry ensure they reach vulnerable populations in these countries while protecting patent rights?